{
    "nct_id": "NCT05281237",
    "official_title": "Feasibility and Efficacy of the AveCure Flexible Microwave Ablation Probe for Peripheral Lung Nodule",
    "inclusion_criteria": "* Subject with Stage I - II primary lung cancer (Solitary nodules up to 3 cm) as defined by previous pathology or ROSE.\n* Pathological proof of target nodule/tumor type and malignancy with specimen considered adequate per institutional laboratory standards\n* Target nodule/tumor which can be accessed via navigational bronchoscopy and confirmed location with cone beam CT scan intra-operatively\n* Resection/surgical candidate (lobectomy or greater)\n* Participants must be at least 22 years old and able to provide consent\nHealthy volunteers allowed\nMust have minimum age of 22 Years",
    "exclusion_criteria": "* Subjects in whom flexible bronchoscopy is contraindicated\n* Target nodule < 1.0 cm\n* Prior radiation or neo adjuvant chemotherapy of the target nodule/tumor\n* Any comorbidity that the investigator feels would interfere with the safety of the subject or the evaluation of study objectives\n* Pacemaker, implantable cardioverter, or another electronic implantable device\n* Patient cannot tolerate bronchoscopy\n* Patients with coagulopathy\n* Patients in other therapeutic lung cancer studies\n* Subject is pregnant or breastfeeding\n* COVID-19 positive patient at the time of procedure.",
    "miscellaneous_criteria": ""
}